Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis

Pediatrics

Volumn 106, Issue 2 I, 2000, Pages 362-366

  Abramson, J S ^a   Baker, C J ^a   Fisher, M C ^a   Gerber, M A ^a   Meissner, H C ^a   Murray, D L ^a   Overturf, G D ^a   Prober, C G ^a   Rennels, M B ^a   Saari, T N ^a   Weiner, L B ^a   Whitley, R J ^a   Peter, G ^a   Pickering, L K ^a   MacDonald, N E ^a   Chilton, L ^a   Delage, G ^a   Dowell, S F ^a   Jacobs, R F ^a   Myers, M G ^a   Orenstein, W A ^a   Patriarca, P A ^a   Ledbetter, E O ^a   Kim, J ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC PROPHYLAXIS; ASPLENIA; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INFANT; INFECTION RISK; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SEROTYPE; SICKLE CELL ANEMIA; STREPTOCOCCUS INFECTION; UNITED STATES;

EID: 0033869176     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.106.2.362     Document Type: Review

References (3)

1. Recommendations for using pneumococcal vaccine in children
2. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
3. Technical report: Prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis